Jeffrey Paullus PA

Recommended Articles

• Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients

  Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...

• Water Breaking Before Labor: What You Need to Know

  Pregnancy is a beautiful experience for all women; however, many precautions must be taken during the complete nine months that a mother carries their child. As a woman reaches her third trimester, it is important to be extra careful and look out for any signs of labor. The need for care only...

• What Is the Bariatric Surgery Diet?

  Bariatric Surgery is a type of procedure done by well experienced surgeons with the purpose of reducing weight. It is an operation also referred to as weight loss surgery. Bariatric Surgery is mostly performed on people who are obese.How Is Bariatric Surgery Done?Bariatric surgery is a process that...

• Does Hypertension Have Warning Signs?

  With modern life complexities becoming more evident, instances of lifestyle health conditions like hypertension have been on the rise. According a recent report, the number of people living with hypertension is estimated to reach 1.56 billion worldwide by the year 2025. In the US, more than 75% of...

• What Is the Difference Between Warfarin and Plavix?

  Differences in Description Warfarin is an anticoagulant or blood thinner under the brand names Coumadin and Jantoven. It is used to prevent the formation and migration of blood clots. Originally, it was marketed as a pesticide. Since then, it has become one of the most frequently prescribed oral...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...